Zobrazeno 1 - 10
of 286
pro vyhledávání: '"YASUHIRO SAKAMOTO"'
Publikováno v:
Frontiers in Built Environment, Vol 10 (2024)
The use of high-strength concrete in construction is expected to increase, and the manufacturing technology employed to produce such concrete needs to adapt to this rise. High-strength concrete has a workability that can vary significantly depending
Externí odkaz:
https://doaj.org/article/3cb47f12edee4cb39ef3200bd64c4221
Autor:
Hiroo Imai, Yasuhiro Sakamoto, Shin Takahashi, Hiroyuki Shibata, Atsushi Sato, Kazunori Otsuka, Kenji Amagai, Masanobu Takahashi, Takuhiro Yamaguchi, Chikashi Ishioka
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Advanced pancreatic cancer is one of the leading causes of cancer-related deaths. For patients with advanced pancreatic cancer, gemcitabine and nanoparticle albumin-binding paclitaxel (nabPTX) combination (GEM/nabPTX) therapy is o
Externí odkaz:
https://doaj.org/article/5310443217344e7f9c587dac657eb026
Autor:
Hisato Kawakami, Yu Sunakawa, Eisuke Inoue, Ryo Matoba, Kenta Noda, Toshiyuki Sato, Chihiro Suminaka, Mami Yamaki, Yasuhiro Sakamoto, Ryohei Kawabata, Atsushi Ishiguro, Yusuke Akamaru, Yosuke Kito, Hiroshi Yabusaki, Jin Matsuyama, Masazumi Takahashi, Akitaka Makiyama, Hidetoshi Hayashi, Kenji Chamoto, Tasuku Honjo, Kazuhiko Nakagawa, Wataru Ichikawa, Masashi Fujii
Publikováno v:
European Journal of Cancer. 184:10-20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3ab91c9bf9a71bdb1f61d40bbca7dbc
https://doi.org/10.1016/j.ejca.2023.02.003
https://doi.org/10.1016/j.ejca.2023.02.003
Autor:
Shin Takahashi, Kota Ouchi, Yasuhiro Sakamoto, Takahiro Mori, Hideki Shimodaira, Masahiro Takahashi, Hisatsugu Ohori, Chieko Kudo, Yoshikazu Takahashi, Hiroo Imai, Shoko Akiyama, Masanobu Takahashi, Takeshi Suto, Yasuko Murakawa, Takayuki Oishi, Hideki Isobe, Yoshinari Okada, Sadayuki Kawai, Takashi Yoshioka, Toshihiko Sato, Yoshiaki Shindo, Shunsuke Sugiyama, Keigo Komine, Natsuko Chiba, Akira Okita, Takuhiro Yamaguchi, Chikashi Ishioka
Publikováno v:
Journal of Gastrointestinal Oncology. 14:676-691
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1c29cda8e66f571638cf39d71e016f8
https://doi.org/10.21037/jgo-22-862
https://doi.org/10.21037/jgo-22-862
Autor:
Takayuki Yoshino, Eiji Oki, Toshihiro Misumi, Masahito Kotaka, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Yasuhiro Sakamoto, Manabu Shiozawa, Masayasu Nishi, Tetsuya Horiuchi, Hisakazu Yamagishi, Junichi Sakamoto, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
Publikováno v:
Journal of Clinical Oncology. 40:3419-3429
PURPOSE The phase III ACHIEVE trial conducted in Japan was one of six prospective studies included in the International Duration Evaluation of Adjuvant Therapy collaboration, which explored whether 3 months of adjuvant fluorouracil, leucovorin, and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1df367b71664c36cd1aaff8500c3d9e7
https://doi.org/10.1200/jco.21.02628
https://doi.org/10.1200/jco.21.02628
Autor:
Yoshikazu Takahashi, Hidekazu Shirota, Takashi Yoshioka, Takuhiro Yamaguchi, Kota Ouchi, Michio Kuroki, Shin Takahashi, Masahiro Takahashi, Masaki Tanaka, Masanobu Takahashi, Chikashi Ishioka, Yasuhiro Sakamoto, Hideki Shimodaira, Hiroo Imai, Satoshi Kato, Keigo Komine, Kazunori Otsuka, Hiroyuki Shibata, Hisatsugu Ohori, Hiroaki Yamaguchi, Yasushi Tsuji
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose The current study aimed to determine the efficacy of trifluridine/tipiracil for elderly patients with advanced colorectal cancer. Methods This single-arm, open-label, multicenter, phase II study included elderly patients aged 65 years or more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2ce1d08d99f5d3d50b44d0848118691
http://hdl.handle.net/10295/00005787
http://hdl.handle.net/10295/00005787
Autor:
Chikashi Ishioka, Kazunori Otsuka, Mariko Kanbe, Yoshiaki Shindo, Ken Saijo, Takashi Yoshioka, Masanobu Takahashi, Hideki Shimodaira, Takuhiro Yamaguchi, Yasuhiro Sakamoto, Kota Ouchi, Sadayuki Kawai, Hiroshi Honda, Yasuko Murakawa, Hidekazu Takahashi, Hisatsugu Ohori, Yuichi Tanaka
Publikováno v:
The Tohoku Journal of Experimental Medicine. 254:49-55
Whether trastuzumab use beyond disease progression is beneficial in second-line treatment for patients with unresectable human epidermal growth factor receptor 2 (HER2)-positive gastric cancer remains to be elucidated. We conducted this phase II stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f55b8440c33ad90bf8280b3812524ef4
https://doi.org/10.1620/tjem.254.49
https://doi.org/10.1620/tjem.254.49
Autor:
Yasufumi Otsuki, Kota Ouchi, Shin Takahashi, Keiju Sasaki, Yasuhiro Sakamoto, Akira Okita, Chikashi Ishioka
Publikováno v:
Cancer science. 113(9)
The cetuximab gene expression signature and DNA methylation status of colorectal cancer (CRC) are predictive of the therapeutic effects of anti-epidermal growth factor receptor (EGFR) antibody therapy. As DNA methylation is a means of regulating gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::596355230260a8aa7be853a0855765d8
https://pubmed.ncbi.nlm.nih.gov/35403373
https://pubmed.ncbi.nlm.nih.gov/35403373
Autor:
Akira Maeda, Riho Yamamoto, Shohei Mizuno, Shigeichiro Miki, Yasuhiro Sakamoto, Shuhei Kogata, Chiyoshi Toyama, Kazuki Sato, Chizu Okamatsu, Takanori Ando, Minako Iida, Toru Watsuji, Toshinobu Sato, Shuji Miyagawa, Hiroomi Okuyama, Akiyoshi Takami, Yoshitaka Kodera
Publikováno v:
Photochemistry and photobiologyReferences. 98(5)
Extracorporeal photochemotherapy (ECP) is one of the more effective cell therapies for graft-versus-host disease (GvHD). ECP is a widely recommended therapeutic approach for the treatment of chronic GvHD, particularly steroid-refractory GVHD. In rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c50de92995329cbb1e0e39c3f672783
https://pubmed.ncbi.nlm.nih.gov/35238039
https://pubmed.ncbi.nlm.nih.gov/35238039
Autor:
TAKASHI YOSHIOKA, MASANOBU TAKAHASHI, YASUHIRO SAKAMOTO, AKIRA OKITA, TADAHISA FUKUI, YASUKO MURAKAWA, YOSHIAKI SHINDO, HIROO IMAI, HISATSUGU OHORI, HIDEKAZU SHIROTA, NATSUKO CHIBA, YURIKO (ITO) SASAHARA, TAKASHI NOMURA, NORIMASA FUKUSHIMA, TAKUHIRO YAMAGUCHI, HIDEKI SHIMODAIRA, CHIKASHI ISHIOKA
Publikováno v:
Anticancer research. 42(4)
This phase II study assessed the efficacy of capecitabine plus cisplatin in patients with advanced gastric cancer refractory to adjuvant S-1.This single-arm, open-label, multicenter, phase II study was conducted by Tohoku Clinical Oncology Research a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d611359f1db4a9f2450e610bcac80f
https://pubmed.ncbi.nlm.nih.gov/35347022
https://pubmed.ncbi.nlm.nih.gov/35347022